Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

As the U.S. fertility rate falls to a 35-year-low, new technologies promise to radically change how we have babies.

Why it matters: The demand for assisted reproductive technology like IVF is likely to grow as people delay the decision to have children. But newer advances in gene editing and diagnostic testing could open the door for a revolution in reproduction, raising ethical questions we haven't begun to answer.

By the numbers: New data from the CDC indicates the U.S. had just 58.2 births per 1,000 women aged 15 to 44 in 2019, a 1% decline from the previous year and the lowest level since 1984.

Between the lines: The one age group in the U.S. where births are increasing is among women over 40, a factor of both delayed marriage and cohabitation and improved fertility technology.

  • From 2009 to 2017, the total number of assisted reproductive technology (ART) cycles increased by more than 8% a year on average.
  • But as more prospective mothers are turning to IVF, the technology is still far from perfect, with live births per IVF cycle actually declining in recent years.

What's happening: New technologies and practices offer some hope for improving IVF in the near future.

  • Researchers tried to train an AI algorithm to identify the quality of embryos and found the model could differentiate between high- and low-quality embryos with about 97% accuracy — higher than most fertility professionals.
  • New York-based TMRW Life Sciences is rolling out an automated platform capable of precisely tracking the eggs and embryos created during the IVF process and keeping them cold, which helps reduce errors that affect success rates.
  • "300 million people are going to be born as a result of IVF this century, driven by all the demographic, economic and cultural forces you can imagine," says Joshua Abram, TMRW's co-CEO. "But at the end of the day, embryology and IVF is really all about specimen management, and we're able to bring that management system into the 21st century."

What's next: IVF is already more than 40 years old, but the next stage of reproductive technology is likely to be even bigger — and even more ethically complex.

  • Prospective parents can already employ preimplantation genetic testing (PGD) to screen IVF-created embryos for hundreds of possible genetic abnormalities. But as both genetic sequencing technology and our knowledge of the genome improves, it's possible parents will be able to screen embryos with far more detail, including for intelligence and even cosmetic traits.
  • As long as IVF remains expensive and uncomfortable, there will be natural limits to its use. But in his fascinating book "The End of Sex," the bioethicist Hank Greely projects a near-future of what he calls "easy PGD," where artificial reproduction — including the ability to screen and select the "best" embryos — essentially displaces making babies the old-fashioned way.
  • As stem cell science improves, Greely predicts parents of the future won't even need to harvest eggs. Instead, skin cells could be reprogrammed to become egg or sperm cells, potentially allowing parents to create thousands or even millions of embryos, and choose the one they want.
  • In such a future, LGBT couples could produce children that share the genes of both partners, and single parents could create a child on their own, by generating both the egg and sperm cells from their own bodies.

Of note: As gene editing improves, parents of the future may not even need to screen and pick embryos, instead writing in the genetic profile they desire.

The catch: This technology doesn't exist for humans yet, and any effort to purposefully edit human embryos for "desirable" traits depends on far greater knowledge of the human genome than scientists currently possess — and raises enormous ethical questions.

  • An international commission concluded in September that gene-editing is still far too immature to introduce heritable DNA modifications into human embryos — but left the door open for changes in the future.

The bottom line: In the future, prospective parents will have a bewildering array of new ways to have children.

Editor's note: This story was corrected to reflect that TMRW does not freeze eggs and embryos but does store them after they are frozen.

Go deeper

2 hours ago - Politics & Policy

Senate Democrats settling on 25% corporate tax rate

Sen. Joe Manchin (D-W.Va.). Photo: Chip Somodevilla/Getty Images

The universe of Democratic senators concerned about raising the corporate tax rate to 28% is broader than Sen. Joe Manchin, and the rate will likely land at 25%, parties close to the discussion tell Axios.

Why it matters: While increasing the rate from 21% to 25% would raise about $600 billion over 15 years, it would leave President Biden well short of paying for his proposed $2.25 trillion, eight-year infrastructure package.

GOP pivot: Big business to small dollars

Illustration: Annelise Capossela/Axios

Republican leaders turned to grassroots supporters and raked in sizable donations after corporations cut them off post-Jan. 6.

Why it matters: If those companies hoped to push the GOP toward the center, they may have done just the opposite by turning Republican lawmakers toward their most committed — and ideologically driven — supporters.

CDC: Half of U.S. adults have received one COVID-19 vaccine dose

Data: CDC; Chart: Axios Visuals

Half of U.S. adults have received at least one dose of the COVID-19 vaccine and about a third are fully vaccinated, according to new data from the Centers for Disease Control and Prevention.

Why it matters: COVID-19 cases and hospitalizations are still on the rise, CDC director Rochelle Walensky said during Friday's White House COVID-19 briefing. With cases in many states being driven by variants, public health officials have emphasized the need to ramp up vaccinations.